TENAX THERAPEUTICS, INC. Quarterly Common Stock, Shares, Issued from Q1 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Tenax Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q1 2011 to Q3 2024.
  • Tenax Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 3.41M shares, a 85.7% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 3.41M -20.5M -85.7% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 1.96M -21.9M -91.8% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 1.96M -19.8M -91% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 298K +270K Dec 31, 2023 10-Q 2024-11-13
Q3 2023 23.9M -6.12M -20.4% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 23.9M -1.34M -5.33% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 21.8M -3.43M -13.6% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 28.6K* -1.23M Dec 31, 2022 10-K 2024-03-28
Q3 2022 30M +4.78M +19% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 25.2M +5.6K +0.02% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 25.2M +10.2M +68.4% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 1.26M -11.4M -90% Dec 31, 2021 10-K 2023-03-31
Q3 2021 25.2M +12.6M +99.7% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 25.2M +15.1M +150% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 15M +6.96M +86.9% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 12.6M +5.88M +87.2% Dec 31, 2020 10-K 2022-03-29
Q3 2020 12.6M +5.88M +87.2% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 10.1M +3.43M +51.4% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 8.01M +1.85M +30.1% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 6.74M +2.95M +77.8% Dec 31, 2019 10-K/A 2021-04-16
Q3 2019 6.74M +5.28M +360% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 6.67M +5.22M +359% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 6.15M +4.7M +323% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 3.79M +2.38M +169% Dec 31, 2018 10-K 2020-03-30
Q3 2018 1.47M -26.8M -94.8% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 1.45M -26.8M -94.9% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 1.45M -26.8M -94.9% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 1.41M +5.84K +0.42% Dec 31, 2017 10-K 2019-04-01
Q3 2017 28.2M +117K +0.42% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 28.2M +117K +0.42% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 28.2M +117K +0.42% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 1.41M -26.7M -95% Dec 31, 2016 10-K 2018-04-02
Q3 2016 28.1M +240 +0% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 28.1M +240 +0% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 28.1M +251 +0% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 28.1M +258 +0% Dec 31, 2015 10-K 2017-03-16
Q3 2015 28.1M +335 +0% Oct 31, 2015 10-Q 2015-12-10
Q2 2015 28.1M +12.3K +0.04% Jul 31, 2015 10-Q 2015-09-09
Q1 2015 28.1M +262K +0.94% Apr 30, 2015 10-KT 2016-03-14
Q4 2014 28.1M +21.3M +313% Jan 31, 2015 10-Q 2015-03-17
Q3 2014 28.1M +21.3M +313% Oct 31, 2014 10-Q 2014-12-15
Q2 2014 28.1M +25M +818% Jul 31, 2014 10-Q 2014-09-15
Q1 2014 27.9M +25.9M +1343% Apr 30, 2014 10-KT 2016-03-14
Q4 2013 6.81M -26.8M -79.8% Jan 31, 2014 10-Q 2014-03-17
Q3 2013 6.81M -26.1M -79.3% Oct 31, 2013 10-Q 2013-12-17
Q2 2013 3.06M -28M -90.1% Jul 31, 2013 10-Q 2013-09-17
Q1 2013 1.93M +459K +31.2% Apr 30, 2013 10-K 2014-07-29
Q4 2012 33.7M +5.42M +19.2% Jan 31, 2013 10-Q 2013-03-18
Q3 2012 32.9M +9.04M +37.9% Oct 31, 2012 10-Q 2012-12-14
Q2 2012 31.1M +7.67M +32.8% Jul 31, 2012 10-Q 2012-09-19
Q1 2012 1.47M -21.9M -93.7% Apr 30, 2012 10-K 2013-06-26
Q4 2011 28.2M Jan 31, 2012 10-Q 2012-03-15
Q3 2011 23.9M Oct 31, 2011 10-Q 2011-12-15
Q2 2011 23.4M Jul 31, 2011 10-Q 2011-09-19
Q1 2011 23.4M Apr 30, 2011 10-K 2012-07-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.